5. Léčba hypoparathyreózy rezistentní na léčbu vitaminem D a vápníkem.
| 53.1 | A11CC04 | kalcitriol | p.o. | 1 | RG | 35,10 | P |
| 47583 | ROCALTROL 0.25 MCG | por cpsmol30x0.25rg | RPS | D |
| 58255 | ROCALTROL 0.25 MCG | por cpsmol30x0.25rg | RPS | D |
| 54 | A11CC | vitamin D a jeho deriváty (ostatní) | p.o. | |
|---|
|
| 54.1 | A11CC01 | ergokalciferol (tekuté lékové formy, do 200 U/ml včetně) | p.o. | 6 KU | 13,10 |
|
| 54.2 | A11CC01 | ergokalciferol (tekuté lékové formy, nad 200 U/ml) | p.o. | 6 KU | 0,78 |
| 00716 | INFADIN | gtt 1x10ml /100mg | SLO | SK |
| 54.3 | A11CC01 | ergocalciferol (pevné lékové formy) | p.o. | 6 | KU | 0,54 | |
| 00353 | VITAMIN D SLOVAKOFARMA | cps 1x300ku | SLO | SK |
| 54.4 | A11CC02 | dihydrotachysterol | p.o. | 1 | MG | 17,13 | |
| 94445 | TACHYSTIN | gtt 1x20ml/20mg | CHV | D |
| 54.5 | A11CC03 | alfakalcidol do 0,50 rg včetně | p.o. | 1 | RG | 18,60 | P |
|
| 54.6 | A11CC03 | alfakalcidol nad 0,50 rg | p.o. | 1 | RG | 17,55 | P |